The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care
- PMID: 30880094
- DOI: 10.1016/j.diabres.2019.03.015
The use of Free Style Libre Continues Glucose Monitoring (FSL-CGM) to monitor the impact of Ramadan fasting on glycemic changes and kidney function in high-risk patients with diabetes and chronic kidney disease stage 3 under optimal diabetes care
Abstract
Aim: To understand the risk of hypoglycaemia during Ramadan fasting by use of CGM, as well as to observe the Glycemic control and renal functions in patients with diabetes and chronic kidney disease stage 3 (CKD-3).
Method: A prospective interventional study conducted in the Dubai Hospital, a tertiary care centre in the United Arab Emirates, during the month of Ramadan 1437 AH (Hijri), which corresponded to June 6th till July 5th, 2016. 25 patients with type 2 diabetes and stage 3 chronic kidney disease (CKD stage 3) were included in the study, who intended to fast during Ramadan. The aim was to observe the serum glucose level through 24 h FreeStyle Libre flash continuous glucose monitor (FSL-CGM). Most patients had three sensors during the study, covering an average three weeks during Ramadan and three weeks outside Ramadan (Sha'ban and shawal). We also monitored the change in, BP, HBA1c, kidney functions and BMI before and after Ramadan.
Results: This study included 25 adults with a mean age of 60 (±14 years). Fasting Ramadan did not result in any significant change in biophysical and biochemical profile of these patients. Data from FSL-CGM showed significantly longer duration (101.9 ± 119.1 Vs. 45.9 ± 47.6 min, p < 0.033) and more frequent hypoglycemic episodes (4.4 ± 4.7 Vs. 2.3 ± 3.0, p < 0.047) during Ramadan compared tonon-Ramadan respectively. The mean blood glucose readings were also significantly lower (70.7 ± 29.3 Vs.93.7 ± 57.9 mg/dl p < 0.011) during Ramadan compared to non -fasting period. The renal function mean ± SD (serum creatinine 1.48 ± 0.37, 1.44 ± 0.37 and eGFR, 49.0 ± 18.4, 48.9 ± 17.5 p 0.9) showed no significant change due to fasting.
Conclusion: In patients with diabetes and CKD-stage 3 Ramadan fasting under close supervision and optimal diabetes care, was not associated with worsening of HBA1c and renal function. Patients had significantly more frequent and prolonged hypoglycemic episodes during Ramadan.
Keywords: CGMS; CKD; Diabetes; Fasting; Hypoglycemia; Ramadan.
Copyright © 2019 Elsevier B.V. All rights reserved.
Similar articles
-
Assessment of risk of fasting during Ramadan under optimal diabetes care, in high-risk patients with diabetes and coronary heart disease through the use of FreeStyle Libre flash continuous glucose monitor (FSL-CGMS).Diabetes Res Clin Pract. 2019 Apr;150:308-314. doi: 10.1016/j.diabres.2019.01.038. Epub 2019 Feb 13. Diabetes Res Clin Pract. 2019. PMID: 30771364
-
The role of optimum diabetes care in form of Ramadan focused diabetes education, flash glucose monitoring system and pre-Ramadan dose adjustments in the safety of Ramadan fasting in high risk patients with diabetes.Diabetes Res Clin Pract. 2019 Apr;150:288-295. doi: 10.1016/j.diabres.2018.12.013. Epub 2019 Jan 11. Diabetes Res Clin Pract. 2019. PMID: 30641167
-
Impact of provision of optimum diabetes care on the safety of fasting in Ramadan in adult and adolescent patients with type 1 diabetes mellitus.Diabetes Res Clin Pract. 2020 Nov;169:108466. doi: 10.1016/j.diabres.2020.108466. Epub 2020 Sep 22. Diabetes Res Clin Pract. 2020. PMID: 32971155
-
The value of Continuous Glucose Monitoring and Self-Monitoring of Blood Glucose in patients with Gestational Diabetes Mellitus during Ramadan fasting.Diabetes Res Clin Pract. 2019 May;151:260-264. doi: 10.1016/j.diabres.2019.01.036. Epub 2019 Feb 26. Diabetes Res Clin Pract. 2019. PMID: 30822494 Review.
-
Use of Continuous Glucose Monitoring in the Assessment and Management of Patients With Diabetes and Chronic Kidney Disease.Front Endocrinol (Lausanne). 2022 Apr 22;13:869899. doi: 10.3389/fendo.2022.869899. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35528010 Free PMC article. Review.
Cited by
-
Ramadan and Diabetes: A Narrative Review and Practice Update.Diabetes Ther. 2020 Nov;11(11):2477-2520. doi: 10.1007/s13300-020-00886-y. Epub 2020 Sep 9. Diabetes Ther. 2020. PMID: 32909192 Free PMC article. Review.
-
Effect of Flash Glucose Monitoring on Glycemic Control, Hypoglycemia, Diabetes-Related Distress, and Resource Utilization in the Association of British Clinical Diabetologists (ABCD) Nationwide Audit.Diabetes Care. 2020 Sep;43(9):2153-2160. doi: 10.2337/dc20-0738. Epub 2020 Jul 15. Diabetes Care. 2020. PMID: 32669277 Free PMC article.
-
Preparing muslims with diabetes mellitus for Ramadan fasting in Singapore: a clinical approach and review of current practice.Singapore Med J. 2022 Nov;63(11):633-640. doi: 10.11622/smedj.2021047. Epub 2021 Apr 19. Singapore Med J. 2022. PMID: 33866748 Free PMC article. Review.
-
Ramadan and Diabetes: A Narrative Review and Practice Update.Diabetes Ther. 2020 Sep 9:1-44. doi: 10.1007/s13300-020-00886-y. Online ahead of print. Diabetes Ther. 2020. PMID: 32922560 Review.
-
Twenty-Four Hour Glucose Profiles and Glycemic Variability during Intermittent Religious Dry Fasting and Time-Restricted Eating in Subjects without Diabetes: A Preliminary Study.Nutrients. 2024 Aug 12;16(16):2663. doi: 10.3390/nu16162663. Nutrients. 2024. PMID: 39203800 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous